Successful intraperitoneal suramin treatment of peritoneal mesothelioma

Annals of Oncology

Volumn 8, Issue 8, 1997, Pages 801-802

  Westermann, A M ^a   Dubbelman, R ^a   Moolenaar, W H ^a   Beijnen, J ^a   Rodenhuis, S ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Intraperitoneal treatment; Mesothelioma; Suramin

Indexed keywords

CLEMASTINE; SURAMIN;

ADULT; ARTICLE; ASCITES; CANCER CHEMOTHERAPY; CASE REPORT; DRUG RESPONSE; FATIGUE; FOLLOW UP; HUMAN; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MESOTHELIOMA; PERITONEUM CANCER; PRIORITY JOURNAL; URTICARIA;

ADULT; ANTINEOPLASTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; MALE; MESOTHELIOMA; PERITONEAL NEOPLASMS; SURAMIN;

EID: 0030929061     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008231901539     Document Type: Article

References (7)

1. Antman KH, Pomfret EA, Aisner J et al. Peritoneal mesothelioma: Natural history and response to chemotherapy. J Clin Oncol 1983; 1 (6): 386-91.
2. Rose GR, Palmer JD, Lougheed MN. Treatment of peritoneal mesothelioma with radioactive colloidal gold. Cancer 1955; 8: 478-81.
3. Moolenaar WH. Lysophosphatidic acid signalling. Curr Opin Cell Biol 1995; 7: 203-10.
4. Van Corven EJ, Van Rijswijk A, Jalink K et al. Mitogenic action of lysophosphatidic acid and phosphatidic acid on fibroblasts. Biochem J 1992; 281: 163-9.
5. Eisenberger MA, Reyno LM. Suramin [Review]. Cancer Treat Rev 1994; 20 (3): 259-73.
6. Stein CA. Suramin: A novel antineoplastic agent with multiple potential mechanisms of action. Cancer Res 1993; 53: 2239-48.
7. Guest PJ, Reznek RH, Selleslag D et al. Peritoneal mesothelioma: The role of computed tomography in diagnosis and follow up. Clin Radiol 1992; 45 (2): 79-84.